Product News

Mater Private Network is the First Hospital in Ireland and the UK to utilise FARAPULSE ™ PFA System

Mater Private Network is the First Hospital in Ireland and the UK to utilise FARAPULSE ™ PFA System to treat atrial fibrillation

FARAPULSE

Mater Private Network, in partnership with Boston Scientific, has announced today that it is the first hospital network in Ireland and within only 25 centres in the world to introduce FARAPULSE technology for patients undergoing catheter ablation for atrial fibrillation.

Traditionally, catheter ablation to treat atrial fibrillation has relied on thermal energy. This is such as radiofrequency or cryoablation, which ablates all tissue types indiscriminately. It has potential risk to impact adjacent structures such as the oesophagus or phrenic nerve.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free